Literature DB >> 18334827

Evaluating the quality of longitudinal statistical applications in original publications on Alzheimer's disease.

Chengjie Xiong1, Yuxiao Tang, Gerald van Belle, J Philip Miller, Lenore J Launer, John C Morris.   

Abstract

BACKGROUND/AIMS: To evaluate the quality of longitudinal statistical applications in published studies on Alzheimer's disease (AD).
METHODS: A 21-item instrument, the Quality of Longitudinal AD Studies (QLADS), was developed by the research team (4 biostatisticians, 1 neuroepidemiologist, and 1 neurologist). All items were extensively discussed within the team for content validity. After pilot testing on 5 publications, the instrument was revised and tested for reliability with a sample of 40 published longitudinal AD studies randomly sampled from MEDLINE.
RESULTS: Item-specific test-retest reliability coefficients for QLADS ranged from 0.53 to 1.00 with the associated standard error (SE) ranging from 0.02 to 0.13. The test-retest reliability for the overall score over the 21 items was high (intraclass correlation coefficient (ICC) = 0.94, 95% CI 0.90, 0.97). Item-specific inter-rater reliability coefficients for QLADS ranged from 0.46 to 1.00 with the associated SE ranging from 0.07 to 0.18. The inter-rater reliability for the overall score was also high (ICC = 0.87, 95% CI 0.77, 0.93).
CONCLUSIONS: This study indicates that the quality of longitudinal statistical applications in AD publications can be reliably assessed. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2008        PMID: 18334827      PMCID: PMC2857641          DOI: 10.1159/000120024

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  23 in total

1.  An assessment of research methods reported in 103 scientific articles from two Canadian medical journals.

Authors:  R F BADGLEY
Journal:  Can Med Assoc J       Date:  1961-07-29       Impact factor: 8.262

2.  Clinical trial reporting.

Authors:  R Peto
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

3.  Estimation and comparison of changes in the presence of informative right censoring: conditional linear model.

Authors:  M C Wu; K R Bailey
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

4.  Assessing reports of therapeutic trials.

Authors:  N D Lionel; A Herxheimer
Journal:  Br Med J       Date:  1970-09-12

5.  Quantification of agreement in psychiatric diagnosis. A new approach.

Authors:  R L Spitzer; J Cohen; J L Fleiss; J Endicott
Journal:  Arch Gen Psychiatry       Date:  1967-07

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Methodologic standards for controlled clinical trials of early contact and maternal-infant behavior.

Authors:  M E Thomson; M S Kramer
Journal:  Pediatrics       Date:  1984-03       Impact factor: 7.124

8.  Instruments for assessing the quality of drug studies published in the medical literature.

Authors:  M K Cho; L A Bero
Journal:  JAMA       Date:  1994-07-13       Impact factor: 56.272

9.  Independent predictors of cognitive decline in healthy elderly persons.

Authors:  Scott Marquis; M Milar Moore; Diane B Howieson; Gary Sexton; Haydeh Payami; Jeffrey A Kaye; Richard Camicioli
Journal:  Arch Neurol       Date:  2002-04

10.  Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals.

Authors:  Dorene M Rentz; Terri J Huh; Robert R Faust; Andrew E Budson; Leonard F M Scinto; Reisa A Sperling; Kirk R Daffner
Journal:  Neuropsychology       Date:  2004-01       Impact factor: 3.295

View more
  1 in total

Review 1.  Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia.

Authors:  Wallace A Marsh; Deirdre M Monroe; Mitchell F Brin; Conor J Gallagher
Journal:  BMC Neurol       Date:  2014-04-27       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.